Holen Sie sich die Stockscreener-App
16.69
3.09%
0.51
Schlusskurs vom Vortag:
$16.18
Offen:
$16.31
24-Stunden-Volumen:
61,430
Relative Volume:
0.49
Marktkapitalisierung:
$492.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.71%
1M Leistung:
-0.71%
6M Leistung:
+16.24%
1J Leistung:
+27.43%
1-Tages-Spanne:
$16.31
$16.72
1-Wochen-Bereich:
$15.95
$16.72
52-Wochen-Spanne:
$10.55
$17.80
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Firmenname
Abrdn Life Sciences Investors
Sektor
Branche
Telefon
-
Adresse
-
Compare HQL vs DNP, UTG, UTF, ADX, KYN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
16.63 | 478.91M | 0 | 0 | 0 | 0.00 |
DNP
Dnp Select Income Fund Inc
|
10.21 | 3.80B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
39.83 | 3.60B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
25.85 | 2.84B | 0 | 0 | 0 | 0.00 |
ADX
Adams Diversified Equity Fund
|
22.24 | 2.72B | 0 | 0 | 0 | 0.00 |
KYN
Kayne Anderson Energy Infrastructure Fund Inc
|
14.29 | 2.40B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Aktie (HQL) Neueste Nachrichten
abrdn Healthcare Investors (NYSE:HQH) Stock Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Aug Wrap: Can Classover Holdings Inc. deliver alphaGDP Growth & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Earnings Report: Is Abrdn Life Sciences Investors benefiting from innovation trends2026 Support & Resistance & Verified Short-Term Plans - baoquankhu1.vn
Income Plays: Will Abrdn Life Sciences Investors stock recover after earningsMarket Trend Summary & Reliable Trade Execution Plans - baoquankhu1.vn
Short Interest in abrdn Life Sciences Investors (NYSE:HQL) Decreases By 37.6% - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Drop in Short Interest - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Stock Price Up 2.5%Still a Buy? - MarketBeat
Will Abrdn Life Sciences Investors stock deliver long term returnsJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - Naître et grandir
Sentiment Recap: Can Abrdn Healthcare Investors reach all time highs this year2025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 (2026-03-06) - Seeking Alpha
First Trust entities jointly hold 3.02M shares of abrdn Life Sciences Investors (HQL) - Stock Titan
THQTekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses - mx.advfn.com
HQL PE Ratio & Valuation, Is HQL Overvalued - Intellectia AI
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - mx.advfn.com
Layoff Watch: Will Abrdn Life Sciences Investors stock hit new highs in YEARDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 361.3% in February - Defense World
Sectors Review: Will Abrdn Life Sciences Investors stock hit new highs in YEAR2025 Growth vs Value & Comprehensive Market Scan Insights - baoquankhu1.vn
Saba Capital Management, L.P. Reduces Stake in abrdn Life Sciences Investors - GuruFocus
Abrdn World Healthcare Fund Q4 2025 Commentary (THW) - Seeking Alpha
Abrdn Life Sciences Investors Fund Q4 2025 Commentary (HQL) - Seeking Alpha
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Aug Swings: Should I hold or sell Abrdn Healthcare Investors nowRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Saba Capital details 4.95% stake in abrdn Life Sciences (HQL) - Stock Titan
Abrdn Healthcare Opportunities Fund Q4 2025 Commentary - Seeking Alpha
What is Abrdn Life Sciences Investors s 5 year growth outlookWeekly Trend Report & Technical Pattern Based Signals - mfd.ru
Will Abrdn Life Sciences Investors benefit from rising consumer demandJuly 2025 Update & Verified Entry Point Signals - mfd.ru
Abrdn Healthcare Investors Fund Q4 2025 Commentary - Seeking Alpha
Aug Macro: Can THCH reach all time highs this yearQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-19) - Seeking Alpha
Abrdn Healthcare Investors: - marketscreener.com
Abrdn Life Sciences Investors To Go Ex-Dividend On February 20th, 2026 With 0.56 USD Dividend Per Share - 富途牛牛
abrdn Healthcare Investors (NYSE:HQH) Reaches New 12-Month HighTime to Buy? - MarketBeat
Abrdn Healthcare Investors stock hits 52-week high at $19.98 By Investing.com - Investing.com Australia
Will Abrdn Life Sciences Investors stock recover after earningsTake Profit & Fast Moving Stock Watchlists - mfd.ru
Market Catalysts: How volatile is Abrdn Life Sciences Investors stockJuly 2025 Review & Fast Entry Momentum Alerts - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Decline in Short Interest - MarketBeat
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately (2026-02-14) - Seeking Alpha
Why Abrdn Life Sciences Investors stock is favored by top institutionsEarnings Beat & Community Shared Stock Ideas - mfd.ru
MREO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-14) - Seeking Alpha
Is Abrdn Healthcare Investors forming a double bottom2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Will Abrdn Healthcare Investors stock deliver long term returnsQuarterly Profit Review & Breakout Confirmation Trade Signals - mfd.ru
abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update - MarketBeat
Should I add Abrdn Life Sciences Investors stock to my portfolio2025 Top Gainers & Weekly Breakout Watchlists - mfd.ru
Will Abrdn Healthcare Investors stock hit new highs in YEARStock Surge & Free Fast Entry Momentum Trade Alerts - mfd.ru
Should value investors consider Abrdn Healthcare InvestorsTrade Exit Report & Verified Momentum Stock Alerts - mfd.ru
What’s the outlook for Abrdn Life Sciences Investors’s sectorJuly 2025 Momentum & Stepwise Trade Signal Guides - mfd.ru
abrdn Healthcare Investors (NYSE:HQH) Sets New 52-Week HighShould You Buy? - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Increases Dividend to $0.56 Per Share - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) to Issue Dividend Increase$0.63 Per Share - MarketBeat
VIX Spike: What’s the outlook for Abrdn Life Sciences Investors’s sectorTreasury Yields & Verified Swing Trading Watchlists - mfd.ru
abrdn Healthcare Investors (HQH) Declares $0.63 Dividend - GuruFocus
Finanzdaten der Abrdn Life Sciences Investors-Aktie (HQL)
Es liegen keine Finanzdaten für Abrdn Life Sciences Investors (HQL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):